Sitagliptin 50 mg

DRUG3 trials

Sponsors

Merck Sharp & Dohme LLC, Sadat City University

Conditions

Diabete Type 2Glucose IntoleranceType 2 Diabetes Mellitus

Phase 2

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)

CompletedNCT01405911

Merck Sharp & Dohme LLCGlucose Intolerance

Start: 2011-08-16End: 2012-04-09Updated: 2020-01-18

Phase 3

Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)

CompletedNCT01076088

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2010-11-15End: 2012-12-24Updated: 2017-05-23

Unknown Phase

Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?

CompletedNCT05359341

Sadat City UniversityDiabete Type 2

Start: 2020-09-20End: 2022-01-10Updated: 2022-05-03